Beta Bionics, Inc.
BBNX
$17.04
$0.331.98%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 31.74% | -13.70% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 31.74% | -13.70% | |||
| Cost of Revenue | 23.85% | -0.95% | |||
| Gross Profit | 39.37% | -23.25% | |||
| SG&A Expenses | 17.38% | 29.08% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 18.82% | 8.38% | |||
| Operating Income | -6.60% | -42.99% | |||
| Income Before Tax | 41.13% | -58.25% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 41.13% | -58.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 41.13% | -58.25% | |||
| EBIT | -6.60% | -42.99% | |||
| EBITDA | -6.47% | -43.22% | |||
| EPS Basic | 58.33% | 65.66% | |||
| Normalized Basic EPS | 58.33% | 65.66% | |||
| EPS Diluted | 58.33% | 65.66% | |||
| Normalized Diluted EPS | 58.33% | 65.66% | |||
| Average Basic Shares Outstanding | 41.27% | 360.80% | |||
| Average Diluted Shares Outstanding | 41.27% | 360.80% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||